{
    "Trade/Device Name(s)": [
        "UCP Drug Screening Test Cups"
    ],
    "Submitter Information": "UCP Biosciences, Inc.",
    "510(k) Number": "k110515",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DIS",
        "JXM",
        "DIO",
        "DJC",
        "DJR",
        "DJG",
        "LCM",
        "LDJ",
        "LFG"
    ],
    "Summary Letter Date": "March 22, 2011",
    "Summary Letter Received Date": "March 22, 2011",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.3100"
    ],
    "Regulation Name(s)": [
        "Amphetamine Test System"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamine",
        "Barbiturates",
        "Benzodiazepines",
        "Cocaine",
        "Marijuana",
        "Methadone",
        "Methamphetamine",
        "MDMA",
        "Morphine",
        "Opiate 2000",
        "Oxycodone",
        "Phencyclidine",
        "Tricyclic Antidepressant",
        "D-Amphetamine",
        "Secobarbital",
        "Oxazepam",
        "Benzoylecgonine",
        "Delta-9-THC-COOH",
        "D-Methamphetamine",
        "Nortriptyline"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Competitive binding immunoassay",
        "Rapid qualitative test"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Test Cup"
    ],
    "Document Summary": "FDA 510(k) summary for UCP Drug Screening Test Cups for rapid qualitative detection of multiple drugs and metabolites in urine.",
    "Indications for Use Summary": "Rapid qualitative immunoassay for detection of various drugs and their metabolites in human urine for preliminary screening; not intended for monitoring drug levels and requires confirmatory testing.",
    "fda_folder": "Toxicology"
}